Biotech · Private company
Galmed Research and Development, Ltd.
Track this companyFree. Adds Galmed Research and Development, Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Aramchol free acidPhase 3 · Nonalcoholic Steatohepatitis (NASH)ClinicalTrials.gov · fetched Nov 12, 2026
- AramcholPhase 2 · Fatty LiverClinicalTrials.gov · fetched Nov 12, 2026
- Aramchol free acid tablet 300mg, bidPhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Aramchol free acid tablet 600mg, single dosePhase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic ImpairmentPHASE1 · COMPLETED · started Feb 13, 2020ClinicalTrials.gov NCT04480827 · fetched Nov 12, 2026
- A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)PHASE3 · SUSPENDED · started Sep 23, 2019ClinicalTrials.gov NCT04104321 · fetched Nov 12, 2026
- A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHPHASE2 · COMPLETED · started Apr 29, 2015ClinicalTrials.gov NCT02279524 · fetched Nov 12, 2026